These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2880951)

  • 21. Ring-substituted amphetamine interactions with neurotransmitter receptor binding sites in human cortex.
    Pierce PA; Peroutka SJ
    Neurosci Lett; 1988 Dec; 95(1-3):208-12. PubMed ID: 2906416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioral effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE; "EVE").
    Boja JW; Schechter MD
    Pharmacol Biochem Behav; 1987 Oct; 28(2):153-6. PubMed ID: 2891144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonergic modulation of rat pup ultrasonic vocal development: studies with 3,4-methylenedioxymethamphetamine.
    Winslow JT; Insel TR
    J Pharmacol Exp Ther; 1990 Jul; 254(1):212-20. PubMed ID: 1973197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MDMA. Nonmedical use and intoxication.
    Siegel RK
    J Psychoactive Drugs; 1986; 18(4):349-54. PubMed ID: 2880950
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat.
    Johnson M; Letter AA; Merchant K; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1988 Mar; 244(3):977-82. PubMed ID: 2472482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
    Callaway CW; Wing LL; Geyer MA
    J Pharmacol Exp Ther; 1990 Aug; 254(2):456-64. PubMed ID: 1974635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of amphetamine analogs on central nervous system neuropeptide systems.
    Hanson GR; Sonsalla P; Letter A; Merchant KM; Johnson M; Bush L; Gibb JW
    NIDA Res Monogr; 1989; 94():259-69. PubMed ID: 2481828
    [No Abstract]   [Full Text] [Related]  

  • 28. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.
    Nash JF; Meltzer HY; Gudelsky GA
    J Pharmacol Exp Ther; 1988 Jun; 245(3):873-9. PubMed ID: 2898523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of amphetamine-like designer drugs on monoaminergic systems in rat brain.
    Gibb JW; Stone DM; Stahl DC; Hanson GR
    NIDA Res Monogr; 1987; 76():316-21. PubMed ID: 2449619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MDMA. The dark side of ecstasy.
    Hayner GN; McKinney H
    J Psychoactive Drugs; 1986; 18(4):341-7. PubMed ID: 2880949
    [No Abstract]   [Full Text] [Related]  

  • 31. The psychological and physiological effects of MDMA on normal volunteers.
    Downing J
    J Psychoactive Drugs; 1986; 18(4):335-40. PubMed ID: 2880948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Some considerations on the prevalence of MDMA use.
    Newmeyer JA
    J Psychoactive Drugs; 1986; 18(4):361-2. PubMed ID: 2880952
    [No Abstract]   [Full Text] [Related]  

  • 33. Controls over the manufacture of MDMA.
    Holsten DW; Schieser DW
    J Psychoactive Drugs; 1986; 18(4):371-2. PubMed ID: 2880954
    [No Abstract]   [Full Text] [Related]  

  • 34. Responses to i.v. L-tryptophan in MDMA users.
    Price LH; Ricaurte GA; Krystal JH; Heninger GR
    NIDA Res Monogr; 1989; 95():421-2. PubMed ID: 2577044
    [No Abstract]   [Full Text] [Related]  

  • 35. Multiple severe complications from recreational ingestion of MDMA ('Ecstasy').
    Brown C; Osterloh J
    JAMA; 1987 Aug; 258(6):780-1. PubMed ID: 2886672
    [No Abstract]   [Full Text] [Related]  

  • 36. Structure-activity relationships of MDMA-like substances.
    Nichols DE; Oberlender R
    NIDA Res Monogr; 1989; 94():1-29. PubMed ID: 2575223
    [No Abstract]   [Full Text] [Related]  

  • 37. MDMA on the street: Analysis Anonymous.
    Renfroe CL
    J Psychoactive Drugs; 1986; 18(4):363-9. PubMed ID: 2880953
    [No Abstract]   [Full Text] [Related]  

  • 38. The complications of 'ecstasy' (MDMA).
    Verebey K; Alrazi J; Jaffe JH
    JAMA; 1988 Mar; 259(11):1649-50. PubMed ID: 2893845
    [No Abstract]   [Full Text] [Related]  

  • 39. Advantages and disadvantages of a rapid method to train drug discrimination.
    Schechter MD
    Pharmacol Biochem Behav; 1988 Sep; 31(1):239-42. PubMed ID: 2908064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-activity relationships of MDMA and related compounds: a new class of psychoactive drugs?
    Nichols DE; Oberlender R
    Ann N Y Acad Sci; 1990; 600():613-23; discussion 623-5. PubMed ID: 1979214
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.